GlassScriptPhysician profile
Michael J Stellmacher
NPI 1144243999
$3,698.06
in general payments reported to CMS, 2019-2025
33 companies · $1,144 in 2025
The $1,144 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $160 · 2022: $253 · 2023: $1,008 · 2024: $1,133 · 2025: $1,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,285.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $752.00 | 2023-2025 | Airsupra, Breztri, Fasenra |
| Abbvie INC. | $461.51 | 2021-2024 | |
| Novo Nordisk INC | $350.59 | 2023-2025 | Ozempic, Rybelsus, Tresiba |
| Idorsia Pharmaceuticals US INC | $320.07 | 2022-2024 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $250.00 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $168.19 | 2025 | |
| Phathom Pharmaceuticals, INC. | $166.53 | 2024 | Voquezna |
| Lexicon Pharmaceuticals, INC. | $154.95 | 2024 | Inpefa |
| Paratek Pharmaceuticals, INC. | $127.78 | 2021-2024 | Nuzyra |
| Exact Sciences Corporation | $122.33 | 2025 | Cologuard Collection Kit |
| Alexion Pharmaceuticals, INC. | $120.06 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $113.64 | 2022-2024 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.14 | 2024-2025 | Jardiance |
| Lilly USA, LLC | $65.75 | 2024-2025 | Mounjaro, Zepbound |
| Antares Pharma, INC. | $43.37 | 2022-2024 | Xyosted, Nocdurna, Tlando |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covis Pharma Gmbh | $39.13 | 2021-2022 | |
| Amgen INC. | $36.86 | 2023-2024 | Repatha, Otezla |
| Biohaven Pharmaceuticals, INC. | $29.04 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.91 | 2022 | |
| Kyowa Kirin, INC. | $26.67 | 2023 | |
| Nabriva Therapeutics, Plc | $26.40 | 2021 | |
| Inspire Medical Systems, INC. | $24.74 | 2025 | Inspire |
| Genentech USA, INC. | $24.48 | 2021 | |
| Eisai INC. | $22.69 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.18 | 2023 | |
| Lucid Diagnostics INC. | $19.29 | 2024 | |
| Abbott Laboratories | $18.59 | 2024 | Freestyle Libre 3 |
| Ibsa Pharma INC. | $17.75 | 2023 | Tirosint, Licart |
| Merck Sharp & Dohme LLC | $17.70 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Boston Scientific Corporation | $14.28 | 2025 | General - Pain Management |
| Kowa Pharmaceuticals America, INC. | $13.63 | 2022 | |
| Phadia US INC. | $13.41 | 2023 | Immunocap |
| Otsuka America Pharmaceutical, INC. | $13.40 | 2023 | Jynarque |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stellmacher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.